Log in to access this content.
FDA is set to consider a new system for heart transplant transportation that aims to extend the lifespan of organs and give surgeons more time to provide transplants.
CMS significantly scaled back its controversial “most favored nation” drug-pricing demonstration in Medicare Part B, issuing a final rule Wednesday (Sept. 30) that will save $440 million over seven ...
Families USA wants elected officials and congressional candidates to explain how they would hold health care corporations accountable for the country’s soaring health care costs, launching a website ...
The Senate will return next week with little chance of passing substantive legislation before the midterm elections, with the House already out, but some movement is planned on HHS nominees before ...
After touting artificial intelligence’s value to the health care system at this week’s MAHA Summit, Secretary Robert F. Kennedy Jr. said Wednesday (Sept. 30) HHS will use AI-involved programs to boost ...
A House Democratic affordability working group has laid out a multi-faceted plan to lower drug prices should their party take back the House in the midterm elections: Expand the scope of Medicare drug ...
The union representing workers at the Centers for Disease Control and Prevention says the agency’s workforce fell 30% from March 2025 to May 2026, losing 8,895 between reductions in force and other ...
CMS wants to sunset one of the pathways that lets states impose higher Medicaid provider taxes, claiming it's rarely used, but Medicaid directors say some states rely on it and hospitals argue ...
FDA officially announced it is considering changes to the Premarket Tobacco Product Application (PMTA) rule, days after FDA commissioner nominee Heidi Overton told lawmakers she was not involved in ...
FDA’s device center is seeking input from stakeholders on novel ways to regulate emerging medical devices, including those used outside of clinical settings and without direct clinician oversight.
The head of health care at Anthropic said his company plans to continue working with HHS on federal artificial intelligence regulations while urging other companies to work together on internal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results